Employees: 553
Size Shanghai Kinetic Medical (300326.SZ) is a China Health Care company (Medical Specialties) with a market value of $662M, the 3021st largest of 4,790 China companies the cockpit tracks. Shares closed at CN¥6.27 on 18 Nov 2026.
Performance Over six months the shares fell 9.8%, against -10.0% for the median peer and -20.0% for the China market (cap-weighted) — 11th highest of 21 in its peer set.
Growth Revenue fell 28.1% over the last twelve months (peer median +17.0%); the operating margin is 17.1% (peer median 12.6%).
Valuation It trades at 26.0× forward earnings against a peer median of 26.7× (9th cheapest of 17).
Price implies For today's price to make sense, revenue must grow about 7% a year for seven years (Req g). Recent delivered growth is -2%, so the hurdle is +9 pp: the price needs faster growth than the company has been delivering — of companies that just grew 25–50% a year, 93.8% slowed down over the next four years.
Capital Return on invested capital runs 0.9 points above its cost of capital (8.3% WACC).
Next results Next results expected around 26 Apr 2027 (exchange calendar; dates can move).
| TTM | FY2025 | FY2024 | FY2023 | FY2022 | |
|---|---|---|---|---|---|
| Revenue | CN¥734M | CN¥960M | CN¥979M | CN¥949M | CN¥1.16B |
| Revenue growth | — | -2% | +3% | -18% | — |
| Gross profit | CN¥504M | CN¥468M | CN¥446M | CN¥444M | CN¥695M |
| EBITDA | n/a | CN¥142M | CN¥163M | CN¥158M | CN¥287M |
| Net income | CN¥269M | CN¥135M | -CN¥106M | CN¥113M | -CN¥21.3M |
| Free cash flow | CN¥249M | CN¥144M | CN¥94.6M | CN¥230M | CN¥203M |
| Capital expenditure | CN¥21.8M | CN¥66.2M | CN¥82.8M | CN¥53.8M | CN¥41.5M |
| Total debt | CN¥50.3M | CN¥54.2M | CN¥326M | CN¥197M | CN¥329M |
The default views of Competitor Analysis ▸ Charts, drawn from the same data. Open them in the cockpit to change the axes, pin companies and read every value.
Peer set: Industry: the same industry and sector in any market, nearest in size. This is the same default set the interactive Competitor Analysis opens with.
| Measure | 300326.SZ | Peer median | Rank in peer set |
|---|---|---|---|
| 1-month return | -4.3% | -1.9% | 9th lowest of 21 |
| 6-month return | -9.8% | -10.0% | 11th highest of 21 |
| Distance from 52-week high | -14.5% | -33.8% | 6th highest of 21 |
| Revenue growth (TTM) | -28.1% | +17.0% | lowest of 21 |
| Operating margin | 17.1% | 12.6% | 9th highest of 21 |
| Forward P/E | 26.0× | 26.7× | 9th cheapest of 17 |
| Growth the price implies (Req g, 7 yrs) | 6.6% | 5.2% | 9th least demanding of 17 |
| Growth delivered (Del g) | -1.9% | +14.3% | lowest of 17 |
| Hurdle (Req g minus delivered) | +8.5 pp | -11.7 pp | 4th most demanding of 17 |
| ROIC minus cost of capital | +0.9 pp | +4.1 pp | 8th lowest of 21 |
| Company | Market | Market cap | 6M return | Revenue growth | Op. margin | Forward P/E | Req g | Delivered g |
|---|---|---|---|---|---|---|---|---|
| Shanghai Kinetic Medical 300326.SZ | China | $662M | -10% | -28% | 17% | 26.0× | 6.6% | -1.9% |
| Synektik SNT.WA | Poland | $662M | +10% | +32% | 24% | 13.8× | 0.2% | +47.5% |
| QuidelOrtho QDEL | United States | $657M | -20% | -5% | -2% | 10.7× | n/a | n/a |
| Shenzhen Sunnypol Optoelectornics 002876.SZ | China | $680M | -9% | +29% | 5% | 39.0× | 10.1% | +14.2% |
| AK Medical 1789.HK | Hong Kong | $642M | -23% | +16% | 26% | 10.5× | -11.5% | +6.7% |
| Delcath Systems DCTH | United States | $685M | +75% | +38% | 5% | 358.9× | 33.4% | +120.2% |
| Livsmed 491000.KS | South Korea | $687M | -47% | +89% | -77% | n/a | n/a | n/a |
| Shenzhen Lifotronic Technology 688389.SS | China | $692M | -14% | +14% | 13% | 29.9× | 11.6% | +13.3% |
| Shanghai Sanyou Medical 688085.SS | China | $692M | -23% | +15% | 4% | 50.0× | 29.0% | +6.8% |
| Beijing Chunlizhengda Medical Instruments 1858.HK | Hong Kong | $631M | -28% | -9% | 31% | 8.5× | -9.5% | +1.5% |
| SunMax Biotechnology 4728.TWO | Taiwan | $630M | 0% | +19% | 51% | n/a | -2.6% | +18.8% |
| Anhui Hongyu Wuzhou Medical Manufacturer 301234.SZ | China | $697M | +148% | -14% | 3% | n/a | 31.8% | -0.6% |
| Shanghai INT Medical Instruments 1501.HK | Hong Kong | $700M | -25% | +35% | 21% | 15.9× | -3.3% | +23.5% |
| Japan Lifeline 7575.T | Japan | $703M | +34% | +6% | 19% | 14.5× | -9.5% | +2.9% |
| SWS Hemodialysis Care 688410.SS | China | $706M | -11% | +31% | 19% | 23.5× | 16.2% | +25.9% |
| Doctorglasses Chain 300622.SZ | China | $710M | -22% | +6% | 14% | 22.8× | -3.4% | +15.7% |
| Xvivo Perfusion XVIVO.ST | Sweden | $611M | -32% | +18% | 12% | 53.1× | 35.9% | +35.2% |
| Caina Technology 301122.SZ | China | $721M | +36% | +61% | 0% | 55.4× | n/a | n/a |
| Nanosonics NAN.AX | Australia | $599M | -4% | +3% | 7% | 98.6× | 35.3% | +6.7% |
| Medistim MEDI.OL | Norway | $599M | +32% | +19% | 29% | 31.8× | -1.2% | +14.5% |
| Sight Sciences SGHT | United States | $599M | +122% | +16% | -30% | n/a | n/a | n/a |